CADM1 and liver cancer: It was also shown that down‐regulation of DLX6‐AS1 may inhibit the stem cell properties of liver cancer stem cells through upregulation of CADM1 by suppressing the methylation of the CADM1 promoter and inactivation of the STAT3 signaling pathway (D.‐M.